Angaben zur Quelle [Bearbeiten]
| Autor | Stéphane Pyronnet, Corinne Bousquet, Souad Najib, Rania Azar, Hanane Laklai, Christiane Susini |
| Titel | Antitumor effects of somatostatin |
| Zeitschrift | Molecular and Cellular Endocrinology |
| Verlag | Elsevier |
| Ausgabe | 281 |
| Datum | 14. May 2008 |
| Nummer | 1-2 |
| Seiten | 230–237 |
| Anmerkung | The page numbering in the documentation refers to the author's manuscript |
| URL | http://www.sciencedirect.com/science/article/pii/S0303720708000646 |
Literaturverz. |
no |
| Fußnoten | no |
| Fragmente | 2 |
| [1.] Clg/Fragment 013 02 - Diskussion Zuletzt bearbeitet: 2014-05-10 22:36:55 Hindemith | Clg, Fragment, Gesichtet, Pyronnet et al 2008, SMWFragment, Schutzlevel sysop, Verschleierung |
|
|
|
| Untersuchte Arbeit: Seite: 13, Zeilen: 2-4 |
Quelle: Pyronnet et al 2008 Seite(n): 2, Zeilen: 2-5 |
|---|---|
| Since its discovery three decades ago, somatostatin has attracted much attention because of its functional role in the regulation of a wide variety of physiological functions in the brain, pituitary, pancreas, kidney, gastrointestinal tract, thyroid, adrenals, and immune system. | Since its discovery three decades ago as an inhibitor of GH release from the pituitary gland, somatostatin has attracted much attention because of its functional role in the regulation of a wide variety of physiological functions in the brain, pituitary, pancreas, gastrointestinal tract, adrenals, thyroid, kidney and immune system. |
The source is not given. |
|
| [2.] Clg/Fragment 013 12 - Diskussion Zuletzt bearbeitet: 2014-05-10 23:11:25 Hindemith | Clg, Fragment, Gesichtet, Pyronnet et al 2008, SMWFragment, Schutzlevel sysop, Verschleierung |
|
|
|
| Untersuchte Arbeit: Seite: 13, Zeilen: 12-13, 16-28 |
Quelle: Pyronnet et al 2008 Seite(n): 2, 3, Zeilen: 2: 14ff: 3: 1ff |
|---|---|
| The mechanisms whereby somatostatin receptors transduce agonist-induced messages into intracellular responses under different conditions and in different cells are complex. [...] The biological effects of somatostatin are mediated through this family of five G-protein coupled receptors [!] with a high degree of sequence similarity and [!] which have been cloned in the early 1990s. They are encoded by five separate genes, located on five different chromosomes, intronless except for sst2, which is alternatively spliced to generate two isoforms named sst2A and sst2B observed mainly in rat and mouse. They all bind natural peptides, somatostatin 14, somatostatin 28 and cortistatin with similar high affinity (nM range). Only sst5 displays a 10-fold higher affinity for somatostatin 28 (Patel, 1999). Because of naturally occurring somatostatins have short half-lives in circulation (1-3 min), synthetic derivatives have been designed to produce more stable compounds. Among the many hundreds of somatostatin analogs that have been synthesized, two analogs are in common clinical use for the treatment of patients with acromegaly and gastroenteropancreatic (GEP) endocrine tumors: octreotide and lanreotide. A third, vapreotide (Sanvar®) which has been well characterized in preclinical studies for its negative effect on cell proliferation is under clinical trials (Gonzalez-Barcena et al., 2003). | The mechanisms whereby somatostatin receptors transduce agonist-induced messages into intracellular responses under different conditions and in different cells are complex. The
biological effects of somatostatin are mediated through a family of five G-protein coupled receptors (GPCR) (sst1-sst5) with a high degree of sequence similarity (39-57 %) and [!] which have been cloned in the early 1990s. They are encoded by 5 separate genes, located on 5 different chromosomes, intronless except for sst2, which is alternatively spliced to generate two isoforms named sst2A and sst2B observed mainly in rat and mouse. They all bind natural peptides, somatostatin 14, somatostatin 28 and cortistatin with similar high affinity (nM range). Only sst5 displays a 10-fold higher affinity for somatostatin 28 (Patel 1999) (Guillermet-Guibert et al., 2005; Weckbecker et al., 2003). Because of naturally occurring [page 3] somatostatins have short half-lives in circulation (1-3 min), synthetic derivatives have been designed to produce more stable compounds. Among the many hundreds of somatostatin analogs that have been synthesized, two analogs are in common clinical use for the treatment of patients with acromegaly and gastroenteropancreatic (GEP) endocrine tumors: octreotide and lanreotide. A third, vapreotide (Sanvar®) which has been well characterized in preclinical studies for its negative effect on cell proliferation is under clinical trials (Gonzalez-Barcena et al., 2003). |
The source is not given. There are similarities in the preceding sentence (line 8-11, not given in the text above), too. Also the omitted sentence (beginning in line 13) exhibits some similarities. The unnecessary additional space character before "with a high degree of sequence" indicates the practice of copy & paste. The confusing grammar in this sentence is already given in the corresponding source text, too. |
|